No abstract available
Keywords:
cerebrovascular disease; clinical management; neuropharmacology; neuroprotection; stroke.
Grants and funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (82374244) and National Key Clinical Specialties Construction Program.